4th Year MBBS
Neuroscience
Seizures and Epilepsy: Clinical Evaluation, Status Epilepticus and Anti-Seizure Pharmacotherapy
A rapid integration of seizure mechanism, clinical recognition, investigation and anti-seizure pharmacotherapy for KMU-focused revision. :contentReference[oaicite:0]{index=0}
1. THE TOPIC IN ONE CONNECTED FLOW
Seizures result when cerebral excitation exceeds effective inhibition, allowing abnormal synchronized neuronal firing. The clinical pattern depends on whether this activity begins in a focal network or involves bilateral networks from onset. Classification then guides investigation and drug selection, while prolonged seizure activity becomes status epilepticus and requires rapid emergency treatment.
Sodium-channel modulation limits repetitive firing; GABA-enhancing drugs increase inhibition; T-type calcium-channel suppression controls absence seizures; SV2A modulation reduces abnormal transmitter release.
2. KEY CLINICAL CONNECTIONS
Aura or unilateral onset → focal cerebral network → focal seizure may spread bilaterally.
Brief staring + immediate recovery → generalized absence pattern → typical EEG shows generalized 3-Hz spike-and-wave activity.
Tonic-clonic activity + lateral tongue injury + postictal confusion → epileptic seizure.
Prodromal sweating/light-headedness + rapid orientation after collapse → syncope more likely.
Focal seizures → sodium-channel modulation → carbamazepine or other appropriate agents.
Typical absence seizures → T-type Ca2+ current suppression → ethosuximide; mixed generalized seizure types may require a broad-spectrum drug.
Ongoing convulsive activity → airway/breathing/circulation + glucose assessment → rapid benzodiazepine therapy.
Persistent risk of recurrence → longer-acting IV anti-seizure drug → refractory cases require intensive-care management.
